Expert Ratings for SouthState
Analysts have provided the following ratings for SouthState (NASDAQ:SSB) within the last quarter:
Raymond James Maintains Outperform on SouthState, Lowers Price Target to $90
Raymond James analyst Michael Rose maintains SouthState (NASDAQ:SSB) with a Outperform and lowers the price target from $93 to $90.
Merger Arbitrage Mondays – Healthcare Trust Of America To Combine With Healthcare Realty Trust
Merger activity increased last week with six new deals announced and six deals completed. Three of the six new deals announced were potential deals in the works.
Healthcare Trust of America (NYSE: HTA)
Raymond James Maintains Outperform on SouthState, Raises Price Target to $92
Raymond James analyst Michael Rose maintains SouthState (NASDAQ:SSB) with a Outperform and raises the price target from $90 to $92.
SouthState: Q4 Earnings Insights
SouthState (NASDAQ:SSB) reported its Q4 earnings results on Monday, January 24, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings Scheduled For January 24, 2022
Companies Reporting Before The Bell
• Sify Technologies (NASDAQ:SIFY) is likely to report earnings for its third quarter.
A Preview Of South State’s Earnings
South State (NASDAQ:SSB) is set to give its latest quarterly earnings report on Monday, 2022-01-24. Here's what investors need to know before the announcement.
Analysts estimate that South State will likely report an Earnings Per Share (EPS) of $1.52.
Raymond James Upgrades SouthState to Outperform, Announces $90 Price Target
Raymond James analyst Michael Rose upgrades SouthState (NASDAQ:SSB) from Market Perform to Outperform and announces $90 price target.